Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

GLUT-1 deficiency without epilepsy--an exceptional case.

W C G Overweg-Plandsoen1, J E M Groener, D Wang

  • 1Department of Paediatric Neurology, Leiden University Medical Centre, Leiden, The Netherlands. w.c.g.plandsoen.neurology@lumc.nl

Journal of Inherited Metabolic Disease
|November 8, 2003
PubMed
Summary

Glucose transporter type 1 (GLUT-1) deficiency is a rare metabolic disorder. A ketogenic diet, particularly medium-chain triglyceride-based, effectively managed symptoms in a non-epileptic child with GLUT-1 deficiency.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dysfunction of proprioceptive sensory synapses is a pathogenic event and therapeutic target in mice and humans with spinal muscular atrophy.

medRxiv : the preprint server for health sciences·2024
Same author

Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype.

Neurology·2011
Same author

Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy.

Neurology·2010
Same author

Glut1 deficiency and alternating hemiplegia of childhood.

Neurology·2009
Same author

Expanding CEP290 mutational spectrum in ciliopathies.

American journal of medical genetics. Part A·2009
Same author

International symposium on pediatric neurotransmitter diseases.

Journal of inherited metabolic disease·2009

Area of Science:

  • Neurology
  • Metabolic Disorders
  • Neurogenetics

Background:

  • Glucose transporter type 1 (GLUT-1) deficiency is a rare inherited metabolic disorder.
  • It impairs glucose transport across the blood-brain barrier, leading to neurological dysfunction.
  • Classic symptoms include epilepsy, developmental delay, ataxia, and hypotonia.

Observation:

  • A 9-year-old boy presented with intellectual disability and ataxia, but notably lacked epilepsy.
  • Biochemical and DNA analyses confirmed GLUT-1 deficiency as the cause.
  • This case highlights a variant presentation of GLUT-1 deficiency.

Findings:

  • Treatment with a medium-chain triglyceride (MCT) ketogenic diet demonstrated a beneficial effect.
  • The diet helped manage the neurological symptoms in this non-epileptic patient.

Related Experiment Videos

  • This suggests the ketogenic diet's efficacy extends beyond seizure control in GLUT-1 deficiency.

    • Implications:

    • The findings suggest that ketogenic diet therapy, specifically MCT-based, can be beneficial for GLUT-1 deficiency even in the absence of epilepsy.
    • This broadens the therapeutic considerations for GLUT-1 deficiency management.
    • Further research into the specific mechanisms of MCTs in neurological symptom amelioration is warranted.